Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COMPUGEN LTDCGEN · Entity 6149 | SVP, Business Development | July 29, 2026 | July 30, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COMPUGEN LTD
Report date July 29, 2026 · Filed July 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 47,375 |
Reported balance
After 2026-07-29 transaction · row 1
1 source rowRow 1 · 2026-07-29 · Grant · Acquired 18,000 · Balance 47,375 F1: Represents a restricted stock unit ("RSU") award. The RSUs vest 25% on September 30, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. |
| Share Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.26 · Expires 2036-07-29 | Direct | 24,000 |
Reported balance
After 2026-07-29 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-29 · Grant · Acquired 24,000 · Balance 24,000 F2: This option vests 25% on September 30, 2027 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted stock unit ("RSU") award. The RSUs vest 25% on September 30, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
F2: This option vests 25% on September 30, 2027 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 29, 2026 Filed Jul 30, 2026 20:13 UTC | COMPUGEN LTD CGEN · Entity 6149 | GrantShare Option (right to buy) · Derivative | 24,000 | $0.00 Strike: $2.26 | $0.00 |
DisclosureSEC source: 0001178913-26-003729 · zk2635776.xml · derivative · entry 2 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Ordinary Shares · 24,000 shares Expires 2036-07-29 F2 · derivative.exercise_date: This option vests 25% on September 30, 2027 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 20:13 UTC | COMPUGEN LTD CGEN · Entity 6149 | GrantOrdinary Shares | 18,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-26-003729 · zk2635776.xml · nonDerivative · entry 1 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,375 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs vest 25% on September 30, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| July 09, 2026 Filed Jul 13, 2026 20:01 UTC | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionShare Option (right to buy) · Derivative | 1,875 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001178913-26-003472 · zk2635673.xml · derivative · entry 3 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,750 Underlying: Ordinary Shares · 1,875 shares Expires 2032-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. F2 · derivative.exercise_date: This option vested 25% on December 31, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| July 09, 2026 Filed Jul 13, 2026 20:01 UTC | COMPUGEN LTD CGEN · Entity 6149 | SaleOrdinary Shares | 1,875 | $2.50 | $4,687.50 |
DisclosureSEC source: 0001178913-26-003472 · zk2635673.xml · nonDerivative · entry 2 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,375 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
| July 09, 2026 Filed Jul 13, 2026 20:01 UTC | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionOrdinary Shares | 1,875 | $0.83 | $1,554.75 |
DisclosureSEC source: 0001178913-26-003472 · zk2635673.xml · nonDerivative · entry 1 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
| April 24, 2026 Filed Apr 27, 2026 20:03 UTC | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionShare Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001178913-26-002245 · ownership.xml · derivative · entry 3 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,000 Underlying: Ordinary Shares · 2,000 shares Expires 2033-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. F2 · derivative.exercise_date: This option vested 25% on September 30, 2024 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| April 24, 2026 Filed Apr 27, 2026 20:03 UTC | COMPUGEN LTD CGEN · Entity 6149 | SaleOrdinary Shares | 2,000 | $3.20 | $6,400.00 |
DisclosureSEC source: 0001178913-26-002245 · ownership.xml · nonDerivative · entry 2 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,375 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
| April 24, 2026 Filed Apr 27, 2026 20:03 UTC | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionOrdinary Shares | 2,000 | $1.15 | $2,300.00 |
DisclosureSEC source: 0001178913-26-002245 · ownership.xml · nonDerivative · entry 1 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
| April 14, 2026 Filed Apr 15, 2026 20:07 UTC | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionShare Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001178913-26-002131 · zk2635084.xml · derivative · entry 3 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,000 Underlying: Ordinary Shares · 2,000 shares Expires 2033-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. F2 · derivative.exercise_date: This option vested 25% on September 30, 2024 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| April 14, 2026 Filed Apr 15, 2026 20:07 UTC | COMPUGEN LTD CGEN · Entity 6149 | SaleOrdinary Shares | 2,000 | $2.80 | $5,600.00 |
DisclosureSEC source: 0001178913-26-002131 · zk2635084.xml · nonDerivative · entry 2 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,375 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
| April 14, 2026 Filed Apr 15, 2026 20:07 UTC | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionOrdinary Shares | 2,000 | $1.15 | $2,300.00 |
DisclosureSEC source: 0001178913-26-002131 · zk2635084.xml · nonDerivative · entry 1 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
| April 10, 2026 Filed Apr 13, 2026 20:04 UTC | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionShare Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001178913-26-002089 · zk2635070.xml · derivative · entry 5 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,000 Underlying: Ordinary Shares · 2,000 shares Expires 2033-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. F4 · derivative.exercise_date: This option vested 25% on September 30, 2024 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| April 10, 2026 Filed Apr 13, 2026 20:04 UTC | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionShare Option (right to buy) · Derivative | 1,125 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001178913-26-002089 · zk2635070.xml · derivative · entry 4 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,625 Underlying: Ordinary Shares · 1,125 shares Expires 2032-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. F3 · derivative.exercise_date: This option vested 25% on December 31, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| April 10, 2026 Filed Apr 13, 2026 20:04 UTC | COMPUGEN LTD CGEN · Entity 6149 | SaleOrdinary Shares | 3,125 | $2.56 | $8,012.50 |
DisclosureSEC source: 0001178913-26-002089 · zk2635070.xml · nonDerivative · entry 3 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,375 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 10, 2026 Filed Apr 13, 2026 20:04 UTC | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionOrdinary Shares | 2,000 | $1.15 | $2,300.00 |
DisclosureSEC source: 0001178913-26-002089 · zk2635070.xml · nonDerivative · entry 2 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
| April 10, 2026 Filed Apr 13, 2026 20:04 UTC | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionOrdinary Shares | 1,125 | $0.83 | $932.85 |
DisclosureSEC source: 0001178913-26-002089 · zk2635070.xml · nonDerivative · entry 1 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
| April 10, 2026 Filed Apr 15, 2026 20:03 UTC Amendment | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionShare Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001178913-26-002128 · zk2635083.xml · derivative · entry 5 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,000 Underlying: Ordinary Shares · 2,000 shares Expires 2033-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. F4 · derivative.exercise_date: This option vested 25% on September 30, 2024 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| April 10, 2026 Filed Apr 15, 2026 20:03 UTC Amendment | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionShare Option (right to buy) · Derivative | 1,125 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001178913-26-002128 · zk2635083.xml · derivative · entry 4 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,625 Underlying: Ordinary Shares · 1,125 shares Expires 2032-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. F3 · derivative.exercise_date: This option vested 25% on December 31, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| April 10, 2026 Filed Apr 15, 2026 20:03 UTC Amendment | COMPUGEN LTD CGEN · Entity 6149 | SaleOrdinary Shares | 3,125 | $2.56 | $8,012.50 |
DisclosureSEC source: 0001178913-26-002128 · zk2635083.xml · nonDerivative · entry 3 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,375 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 10, 2026 Filed Apr 15, 2026 20:03 UTC Amendment | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionOrdinary Shares | 2,000 | $1.15 | $2,300.00 |
DisclosureSEC source: 0001178913-26-002128 · zk2635083.xml · nonDerivative · entry 2 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
| April 10, 2026 Filed Apr 15, 2026 20:03 UTC Amendment | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionOrdinary Shares | 1,125 | $0.83 | $932.85 |
DisclosureSEC source: 0001178913-26-002128 · zk2635083.xml · nonDerivative · entry 1 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
| April 08, 2026 Filed Apr 9, 2026 20:05 UTC | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionShare Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001178913-26-002036 · zk2635040.xml · derivative · entry 8 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,000 Underlying: Ordinary Shares · 1,000 shares Expires 2033-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. F3 · derivative.exercise_date: This option vested 25% on September 30, 2024 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| April 08, 2026 Filed Apr 9, 2026 20:05 UTC | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionShare Option (right to buy) · Derivative | 4,375 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001178913-26-002036 · zk2635040.xml · derivative · entry 7 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,750 Underlying: Ordinary Shares · 4,375 shares Expires 2032-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. F2 · derivative.exercise_date: This option vested 25% on December 31, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| April 08, 2026 Filed Apr 9, 2026 20:05 UTC | COMPUGEN LTD CGEN · Entity 6149 | SaleOrdinary Shares | 5,375 | $2.42 | $13,007.50 |
DisclosureSEC source: 0001178913-26-002036 · zk2635040.xml · nonDerivative · entry 5 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,375 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
| April 08, 2026 Filed Apr 9, 2026 20:05 UTC | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionOrdinary Shares | 1,000 | $1.15 | $1,150.00 |
DisclosureSEC source: 0001178913-26-002036 · zk2635040.xml · nonDerivative · entry 4 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
| April 08, 2026 Filed Apr 9, 2026 20:05 UTC | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionOrdinary Shares | 4,375 | $0.83 | $3,627.75 |
DisclosureSEC source: 0001178913-26-002036 · zk2635040.xml · nonDerivative · entry 3 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 20:05 UTC | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionShare Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001178913-26-002036 · zk2635040.xml · derivative · entry 6 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,125 Underlying: Ordinary Shares · 2,500 shares Expires 2032-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. F2 · derivative.exercise_date: This option vested 25% on December 31, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 20:05 UTC | COMPUGEN LTD CGEN · Entity 6149 | SaleOrdinary Shares | 2,500 | $2.30 | $5,750.00 |
DisclosureSEC source: 0001178913-26-002036 · zk2635040.xml · nonDerivative · entry 2 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,375 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 20:05 UTC | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionOrdinary Shares | 2,500 | $0.83 | $2,073.00 |
DisclosureSEC source: 0001178913-26-002036 · zk2635040.xml · nonDerivative · entry 1 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 11:31 UTC | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionShare Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001178913-26-001990 · ownership.xml · derivative · entry 5 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,000 Underlying: Ordinary Shares · 1,000 shares Expires 2033-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. F3 · derivative.exercise_date: This option vested 25% on September 30, 2024 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 11:31 UTC | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionShare Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001178913-26-001990 · ownership.xml · derivative · entry 4 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,625 Underlying: Ordinary Shares · 2,500 shares Expires 2032-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. F2 · derivative.exercise_date: This option vested 25% on December 31, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 11:31 UTC | COMPUGEN LTD CGEN · Entity 6149 | SaleOrdinary Shares | 3,500 | $2.20 | $7,700.00 |
DisclosureSEC source: 0001178913-26-001990 · ownership.xml · nonDerivative · entry 3 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,375 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 11:31 UTC | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionOrdinary Shares | 1,000 | $1.15 | $1,150.00 |
DisclosureSEC source: 0001178913-26-001990 · ownership.xml · nonDerivative · entry 2 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 11:31 UTC | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionOrdinary Shares | 2,500 | $0.83 | $2,073.00 |
DisclosureSEC source: 0001178913-26-001990 · ownership.xml · nonDerivative · entry 1 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 22:04 UTC | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionShare Option (right to buy) · Derivative | 11,875 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001178913-26-001896 · zk2634987.xml · derivative · entry 3 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,125 Underlying: Ordinary Shares · 11,875 shares Expires 2032-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. F3 · derivative.exercise_date: This option vested 25% on December 31, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 22:04 UTC | COMPUGEN LTD CGEN · Entity 6149 | SaleOrdinary Shares | 11,875 | $2.04 | $24,187.00 |
DisclosureSEC source: 0001178913-26-001896 · zk2634987.xml · nonDerivative · entry 2 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,375 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.02 to $2.10 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 22:04 UTC | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionOrdinary Shares | 11,875 | $0.83 | $9,846.75 |
DisclosureSEC source: 0001178913-26-001896 · zk2634987.xml · nonDerivative · entry 1 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.